Condition: Aortic Dissection · Sponsor: W.L.Gore & Associates
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
This description comes directly from the study's public registry record.
Clinical Study Manager · 800-437-8181 · ARISE3Pivotal@wlgore.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| University of Southern California | Los Angeles, California, United States | Recruiting |
| The Stanford Hospital | Palo Alto, California, United States | Recruiting |
| University of Florida | Gainesville, Florida, United States | Recruiting |
| Emory University School of Medicine | Atlanta, Georgia, United States | Recruiting |
| Northwestern Medicine | Chicago, Illinois, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Corewell Health System | Grand Rapids, Michigan, United States | Recruiting |
| Washington University School of Medicine - St. Louis | St Louis, Missouri, United States | Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06827990